Literature DB >> 23427248

Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes.

Xiaotian Lin1, Emma E Hamilton-Williams, Daniel B Rainbow, Kara M Hunter, Yang D Dai, Jocelyn Cheung, Laurence B Peterson, Linda S Wicker, Linda A Sherman.   

Abstract

In the NOD mouse model of type 1 diabetes, insulin-dependent diabetes (Idd) loci control the development of insulitis and diabetes. Independently, protective alleles of Idd3/Il2 or Idd5 are able to partially protect congenic NOD mice from insulitis and diabetes, and to partially tolerize islet-specific CD8(+) T cells. However, when the two regions are combined, mice are almost completely protected, strongly suggesting the existence of genetic interactions between the two loci. Idd5 contains at least three protective subregions/causative gene candidates, Idd5.1/Ctla4, Idd5.2/Slc11a1, and Idd5.3/Acadl, yet it is unknown which of them interacts with Idd3/Il2. Through the use of a series of novel congenic strains containing the Idd3/Il2 region and different combinations of Idd5 subregion(s), we defined these genetic interactions. The combination of Idd3/Il2 and Idd5.3/Acadl was able to provide nearly complete protection from type 1 diabetes, but all three Idd5 subregions were required to protect from insulitis and fully restore self-tolerance. By backcrossing a Slc11a1 knockout allele onto the NOD genetic background, we have demonstrated that Slc11a1 is responsible for the diabetes protection resulting from Idd5.2. We also used Slc11a1 knockout-SCID and Idd5.2-SCID mice to show that both loss-of-function alleles provide protection from insulitis when expressed on the SCID host alone. These results lend further support to the hypothesis that Slc11a1 is Idd5.2.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427248      PMCID: PMC3608810          DOI: 10.4049/jimmunol.1203422

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

Review 1.  Localising quantitative trait loci in the NOD mouse model of type 1 diabetes.

Authors:  P A Lyons; L S Wicker
Journal:  Curr Dir Autoimmun       Date:  1999

2.  Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood.

Authors:  Jacqueline D Trudeau; Carolyn Kelly-Smith; C Bruce Verchere; John F Elliott; Jan P Dutz; Diane T Finegood; Pere Santamaria; Rusung Tan
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

3.  The generic genome browser: a building block for a model organism system database.

Authors:  Lincoln D Stein; Christopher Mungall; ShengQiang Shu; Michael Caudy; Marco Mangone; Allen Day; Elizabeth Nickerson; Jason E Stajich; Todd W Harris; Adrian Arva; Suzanna Lewis
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

4.  Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice.

Authors:  Sue M Liu; David H Lee; Jenna M Sullivan; Denise Chung; Anneli Jäger; Bennett O V Shum; Nora E Sarvetnick; Ana C Anderson; Vijay K Kuchroo
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

5.  Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.

Authors:  K B Cox; D A Hamm; D S Millington; D Matern; J Vockley; P Rinaldo; C A Pinkert; W J Rhead; J R Lindsey; P A Wood
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

6.  Inducible IL-2 production by dendritic cells revealed by global gene expression analysis.

Authors:  F Granucci; C Vizzardelli; N Pavelka; S Feau; M Persico; E Virzi; M Rescigno; G Moro; P Ricciardi-Castagnoli
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

7.  NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans.

Authors:  N J Hill; P A Lyons; N Armitage; J A Todd; L S Wicker; L B Peterson
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

8.  Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes.

Authors:  H J Cordell; J A Todd; N J Hill; C J Lord; P A Lyons; L B Peterson; L S Wicker; D G Clayton
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

9.  Cellular mechanisms of restored β-cell tolerance mediated by protective alleles of Idd3 and Idd5.

Authors:  Emma E Hamilton-Williams; Jocelyn Cheung; Daniel B Rainbow; Kara M Hunter; Linda S Wicker; Linda A Sherman
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

10.  Confirmation of novel type 1 diabetes risk loci in families.

Authors:  J D Cooper; J M M Howson; D Smyth; N M Walker; H Stevens; J H M Yang; J-X She; G S Eisenbarth; M Rewers; J A Todd; B Akolkar; P Concannon; H A Erlich; C Julier; G Morahan; J Nerup; C Nierras; F Pociot; S S Rich
Journal:  Diabetologia       Date:  2012-01-26       Impact factor: 10.122

View more
  14 in total

1.  Congenic mice reveal genetic epistasis and overlapping disease loci for autoimmune diabetes and listeriosis.

Authors:  Nancy Wang; Colleen M Elso; Leanne Mackin; Stuart I Mannering; Richard A Strugnell; Odilia L Wijburg; Thomas C Brodnicki
Journal:  Immunogenetics       Date:  2014-06-07       Impact factor: 2.846

2.  Autoimmune-Disease-Prone NOD Mice Help To Reveal a New Genetic Locus for Reducing Pulmonary Disease Caused by Mycoplasma pulmonis.

Authors:  Glenn F Browning; Thomas C Brodnicki; Nadeeka K Wawegama; Philip F Markham; Colleen M Elso; Anna Kanci; Marc S Marenda
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

3.  Functional validation of the genetic architecture of Salmonella Enteritidis persistence in 129S6 mice.

Authors:  Marie Chevenon; Mayss Naccache; Megan M Eva; Rabia T Khan; Danielle Malo
Journal:  Mamm Genome       Date:  2013-04-16       Impact factor: 2.957

4.  Analysis of gene-gene interactions using gene-trait similarity regression.

Authors:  Xin Wang; Michael P Epstein; Jung-Ying Tzeng
Journal:  Hum Hered       Date:  2014-06-21       Impact factor: 0.444

5.  A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse.

Authors:  Fabian Jakubczik; Ken Jones; Jennifer Nichols; William Mansfield; Anne Cooke; Nick Holmes
Journal:  Diabetes       Date:  2015-10-08       Impact factor: 9.461

6.  Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.

Authors:  Cini R James; Irina Buckle; Franziska Muscate; Masayuki Otsuka; Mari Nakao; Jack Sh Oon; Raymond J Steptoe; Ranjeny Thomas; Emma E Hamilton-Williams
Journal:  Immunol Cell Biol       Date:  2016-01-14       Impact factor: 5.126

7.  Pathway-guided identification of gene-gene interactions.

Authors:  Xin Wang; Daowen Zhang; Jung-Ying Tzeng
Journal:  Ann Hum Genet       Date:  2014-09-17       Impact factor: 1.670

8.  Type 1 Diabetes Prone NOD Mice Have Diminished Cxcr1 mRNA Expression in Polymorphonuclear Neutrophils and CD4+ T Lymphocytes.

Authors:  Karine Haurogné; Marija Pavlovic; Hélène Rogniaux; Jean-Marie Bach; Blandine Lieubeau
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

9.  Increased autoimmune diabetes in pIgR-deficient NOD mice is due to a "Hitchhiking" interval that refines the genetic effect of Idd5.4.

Authors:  Kim R Simpfendorfer; Richard A Strugnell; Thomas C Brodnicki; Odilia L C Wijburg
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

10.  Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes.

Authors:  Nora M Kochupurakkal; Annie J Kruger; Sudipta Tripathi; Bing Zhu; La Tonya Adams; Daniel B Rainbow; Aldo Rossini; Dale L Greiner; Mohamed H Sayegh; Linda S Wicker; Indira Guleria
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.